chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection was administer at Pediatrics and went home before any symptom started. The child's mom notice swelling to face, arms, neck, SOB child was rushed to ER where she received treatment.
Diagnosed with pneumonia.; Chest and back pain; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 24Jun2021 (at the age of 72-years-old) as dose 2, single for COVID-19 immunization in hospital. No other vaccine was administered in four weeks. No other medications were administered in two weeks. The patient had no covid prior vaccination. The patient was not tested for covid post vaccination. Medical history included, eczema, heart rate irregular. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 03Jun2021 (at the age of 72-years-old) as dose 1, single for covid-19 immunisation in hospital. The patient previously took erythromycin and claritin [clarithromycin] and experienced allergy. On 24Jun2021, the patient was diagnosed with pneumonia and experienced chest and back pain and shortness of breath. The events resulted in physician office visit. Therapeutic measures were taken as a result of the events with antibiotics. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
soreness on the injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (soreness on the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness on the injection site). At the time of the report, VACCINATION SITE PAIN (soreness on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient wanted to know if she could take Ibuprofen. Concomitant product use was not provided by the reporter. No treatment information was provided.
Patient received 2 doses of 1.2mL each dose of Covid-19 Vaccine 5-11 years/old on the same day.
Mild itching at injection site turned to soreness the following morning . No early signs of a cold prior to shot but, woke up with sore throat, sinus congestion and  mild tiredness.
Development of Rheumatoid Arthritis 6 weeks after 2nd shot, with no previous history of autoimmune disease or symptoms.  Patient was in excellent health, a competitive runner, with a healthy diet.  Degeneration of achilles tendon in both ankles, followed by multiple rheumatoid flareups in both feet and right hand and fingers.  RH factor positive.
pt recv vax 24OCT94 & cried for 1 1/2 days (fussy) & leg swelled;
Flushing with slight itch  on Feb 1, Feb 4, Feb 9, Feb 13, Feb 15
cerebral venous sinus thrombosis; CT scan that revealed the clot; horrible headache after intercourse; vomiting; This is a spontaneous report from a contactable consumer (patient). A 29-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EP7534), second dose via an unspecified route of administration, administered in left arm on 25Mar2021 09:45 as single dose for COVID-19 immunisation. Patient was 29 year old at the time of vaccination. Medical history included asthma, gastrooesophageal reflux disease, peanut and treenut allergy, all from an unknown date. Patient had estrogen allergy. Patient was not diagnosed with COVID-19 Prior to or after the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY), medroxyprogesterone acetate (DEPO PROGESTIN), beclometasone dipropionate (QVAR), OMEPRAZOLE, SERTRALINE HYDROCHLORIDE, all taken on an unspecified date and for unknown indication. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had her first dose of bnt162b2 on 04Mar20210 at 9:45 am in left arm for COVID-19 immunisation. On 28Mar2021 at 09:45 the patient was diagnosed with cerebral venous sinus thrombosis a few days after receiving the second dose of the vaccine. She had a horrible headache after intercourse, went to the ER after vomiting, and had a CT scan that revealed the clot. The patient was hospitalized for cerebral venous sinus thrombosis. The patient underwent lab tests and procedures which included computerised tomogram: revealed the clot. Patient received Heparin and Eliquis as treatment for the events. Outcome of the events was recovering.  No follow-up attempts needed. No further information expected.
Patient (age 12) walked off to the area where he was supposed to wait for 15 min after his vaccine was administered. He sat down, and after ~1 min of sitting his arm went stiff, I think legs as well,  Arm was shaking (seizure like) and his head collapsed. He was unconscious.I supported him  and yelled for help, 911 was called. Customer helped me put him down on the floor and he regained consciousness after some time (~1 min)He was pale but answered correctly to  questions asked. Arm and body had no more seizures. Ambulance took him to the hospital and test heart related were run. All test results (EKG, roentgen of the chest and blood results came back normal, according to the ER doctor). MY BIG Question is: Do you recommend him getting a second dose of the Pfizer vaccine? I am terrified after seeing him seizure and faint. His primary care doctor said he has had another boy his age had the same reaction to the shot. I am very very scared.
sickness (Illness); Muscle pain; Joints on fire; Headache; Fever; Chills; Sweats; Cold sores; Diarrhea; This is a spontaneous report from a contactable other hcp reporting on behalf of patient. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: unknown, expiry date: unknown), via an unspecified route of administration on 26Feb2021 (at the age of 58-year-old) as dose number unknown, single dose for covid-19 immunization. Patient's medical history included ongoing otitis externa, covid-19 from Nov2020 to an unknown date (patient was hospitalized for Covid-19 for 5 days) and ongoing osteoporosis from 01Mar2021. Concomitant medications included abaloparatide (TYMLOS) taken subcutaneously for osteoporosis from Jun2020 to 26Feb2021 at 80 mcg OD. On 27Feb2021, the patient experienced sickness (Illness), muscle pain, joint on fire, headache, fever, chills, cold sore, diarrhea and sweats. The patient underwent lab tests and procedures which included body temperature: Fever that went away on 01Mar2021. The outcome of all the events was unknown.   No follow-up attempts are possible. No further information is expected.
Approximately 7 days post vaccine, developed painful left axillary lymphadenopathy. Later that evening, developed nausea, dizziness and urticaria around injection site covering left deltoid area. This is now firm, enlarged, tender and erythematous.
Cellulitis on his elbow; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (Cellulitis on his elbow) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced CELLULITIS (Cellulitis on his elbow) (seriousness criterion medically significant). At the time of the report, CELLULITIS (Cellulitis on his elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment for the event included antibiotics.  Based on the current information and the temporal association between the use of the product and the start date of the event a causal relationship cannot be excluded.; Sender's Comments: Based on the current information and the temporal association between the use of the product and the start date of the event a causal relationship cannot be excluded.
(L) deltoid tenderness, swelling, rash above shoulder and down to elbow approx 3 days. + Fever low grade x 2 days. Mild nausea - no emesis. Patient took Benadryl and Tylenol PRN approx 2 days.
Information has been received from a NP concerning a 25 year old female pt who was vaccinated with a 1st and 2nd dose of Hep-B vaccine on 5/10/00 and 6/8/00. On 5/10/00, the pt's lab results indicated an increase in liver function (serum alanine aminotransferase test(177); serum aspartate aminotransferase test (196). On 6/8/00, the day of the pt's second dose of Hep-B vaccine, the pt's lab results indicated an increase in liver function (serum alanine aminotransferase test (133), serum aspartate aminotransferase test (215). It was noted that prior to the 1st dose of Hep-B, the pt experienced an increase in liver function (4-28-00); serum alanine aminotransferase test (122) and serum aspartate aminotransferase test (88). It was noted that on 5/17/00, the pt discontinued therapy with isoniazid and her serum aspartate aminotransferase test results decreased to 98. No further information is expected.
On the first day I had a huge lump underneath my armpit I did not become too concerned with that I read it was something that could happen regarding the lymph node. 10 days later I woke up at 3:30 in the morning and had to dial 911 my throat felt like it was closing and my lips were both swollen. I went in the ambulance they brought me to the emergency room where they gave me Benadryl a steroid and some IV fluids. as soon as I receive the Benadryl my throat started to open up and my lips both started to go down . My lip continue to swell for the next three days on and off often on. Every time it swelled up I took Benadryl and every time sure enough it went away . The day I came home from the hospital I thought I was doing much better until that following night I became severely nauseous. I don?t know if it was something that they had given me in the hospital or still a reaction that was going on in my body, but I had some sort of stomach bug I threw up that whole day, had chills sweats  and a pounding headache that would not go away for over 48 hours .I was unable to eat or drink for 24 hours and had to go to an urgent care where they provided me with some medication for nausea. My concern right now is I am hearing that the second shot hits a lot harder than the first one and if this was a reaction to the shot I am very afraid of what will go on if I get the second one.  I cannot take a chance with my life.  I really want to shot I work in an environment where I am working with the department  which is why I was able to get the vaccine so early I feel safe being vaccinated I am very disappointed that this happened I just cannot take a chance having a family etc. Also I have very bad medical in Sherance so I am dealing with all of the bills from this hospital stay I have a  deductible which I can?t afford and then only 50% is covered afterwards. That is the reason I do not go to the hospital under no circumstance unless I am dying which that night I was that scared I felt the need I had to go.
Developed runny nose, low grade fever (99.9) and dry cough 7/7/2021. Lost sense of taste and smell 7/10/21. Full resolution of symptoms by 7/16/21.
This spontaneous report as received from a nurse refers to unspecified patients of unknown ages and genders. In August 2017, the patients were vaccinated with a improperly stored doses of M-M-R II which were reconstituted with improperly storage sterile diluent for prophylaxis. No adverse effects reported. Sender's Comments: US-009507513-1708USA012500: US-009507513-1708USA012428.
Welts on face then spreading to stomach.  Child was itching profusely.  Gave child Benadryl.
The right leg was swollen and red. The redness extended from the top portion of his thigh to his knee.
Information has been received on 02-JUL-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 19-JUL-2014, the patient was treated at a medical center for a blistering vesicular outbreak, which was then diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
1st dose on 07Oct2021, 2nd dose on 06May2022; Only received one dose, then had shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number H2PE2, expiry date 19th May 2023) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number T29Y2, expiry date 8th April 2023) for prophylaxis.   On 6th May 2022, the patient received the 2nd dose of Shingrix. On 7th October 2021, the patient received the 1st dose of Shingrix. On 18th April 2022, not applicable after receiving Shingrix and 193 days after receiving Shingrix, the patient experienced shingles. On 6th May 2022, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 9-May-2022 Reporter's Comment: The patient self-reported this case. Member of public stated that she was not aware that two doses were needed for Shingrix, so she only received one dose and then had a shingles outbreak. The shingles outbreak occurred approximately 18th April 2022. After shingles cleared, she received second dose. The reporter consented to follow-up. Additional supportive information: The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccination schedule.
Myalgia, shivering, nausea, low grade fever and one instance of syncope starting the night of vaccination and continuing 16 hours after
Moderna 3/17/21, 4/14/21, 12/2/21. Positive on 8/30
Mother called in on 2/10/2008 to our office to report a reaction to an immunization.  There was an area on the left arm that was warm and swollen.  The middle was red and hard and the size of a quarter.  Ice helps.
Suspected Guillain-Barre'syndrome.  Pt presented with a one and a half week worsening weakness which started in her feet and extended up to her thighs.  Now she has weakness in her arms as well.  She associates the beginning of her symptoms with a flu shot which she got on the 14th.  The same day, she started having some shortness of breath which was similar to her asthma exacerbation.  Shortness of breath did not stay there for a long time, and she has been having it on and off for the last week and a half.  She can walk, but she does not even try to run or go up stairs.  10/28/09 PCP medical records received service dates 10/24/09 to 10/26/09. Includes some ED / hospital records. Assessment: Possibility of Guillain-Barre' Syndrome', hypothyroidism. Patient presents with shortness of breath, exacerbation of asthma, muscles 'rubbery', dizziness, hasn't 'felt right' since flu shot. Chest tightness, some nasal congestion. Progressive muscle weakness feet, thighs, arms. Nasal erythema. Patient severely hypothyroid. Absent deep tendon reflexes. 'Feels like something stuck in back of throat' food gets stuck. Pinprick sensation decreased in lower extremity.  12/1/09 Hospital records, discharge summary, service dates 10/25/09 to 10/27/09. Assessment: Neuropathy unknown etiology. Mild well controlled asthma. Patient presented with lower and upper extremity weakness and sensation changes. Concerns regarding Guillain-Barre syndrome. Ascending pattern of tingling and numbness feet, thighs, arms. Mild dysphagia, feeling that food stuck in throat, shortness of breath with exertion. Decreased deep tendon reflexes, paresthesia, decreased pinprick sensation in feet. Unsteady, dizzy. Difficult tandem gait.
Information has been received from a medical assistant concerning an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical histories and concomitant therapies were not reported. On unknown dates, the patient were vaccinated with improperly stored M-M-R II (lot # M011666 with expiration date  08-MAR-2018; dose and route were unknown; for prophylaxis) that was reconstituted with properly stored STERILE WATER DILUENT which was exposed to temperature excursion of 47 to 77 (46.9) degrees Fahrenheit for 13 hours and 30 minutes. The previous temperature excursions was 47 to 77 (62) degrees Fahrenheit for 2 hours and 30 minutes and 47 to 77 (48) degrees Fahrenheit for 30 minutes. Data logger was not involved. No adverse effects were reported.
Fever 102, hr 120, decreased spo2 94, nausea, vomiting, fatigue, chills, body/joint ache, sore left shoulder.  Most symptoms lasted 36 hrs, nausea and fatuge lasted 48 hrs
Patient reported mild numbness around lips at 06:40 pm after having received COVID 19 vaccine on right deltoid at 06:16 pm via Intramuscular injection. Patient was accessed in her personal vehicle and found alert, coherent, and oriented to person, time, place, and event throughout incident. Patient?s vital signs and status were monitored for 15 minutes  and patient was encouraged to report any worsening symptoms to medical staff on site or emergency services via 911 call.  After 15 minutes, patient reported that her numbness has subsided and was going to continue to monitor her breathing and numbness at home. Patient was instructed to contact emergency services if condition worsened, numbness returned.
Fever, rash, itching, jaundice, swelling of stomach and feet. Eyes every yellow. Now have chronic hepatitis autoimmune liver disease. Acute necrosis.  Take acute necrosis out, term should be advanced fibrosis.  add: ulcett, hiatal hernia.
pt recvd vax & w/in 5-10 mins c/o shaking hands & light headedness; dilated pupils & apnea (apnea estimate x 5-10 sec; 02 administered transported to ER/stretch; In ER t97, P97, R18, BP 138/82; vasovagal rx dx per MD; h/a & aching shoulder;
COVID-19 (12+) administered to patient age 11 y.o. No adverse reactions noted or reported by patient or parents to date.
AFTER RECEIVING THE VACCINE SHE COMPLAINED OF BEING TIRED. ONSITE EMS/PHYSICIAN RESPONDED. BP 154/90 HR 88 SHE REFUSED FURTHER EVAL AND CAREE AND WENT HOME
alopecia areata; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 13-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Apr2022 as dose 3 (booster), single (Lot number: Fk9894) at the age of 13 years for COVID-19 immunisation. The patient's relevant medical history included: "known allergies: grapefruit" (unspecified if ongoing), notes: known allergies: grapefruit; "known allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EW0175), administration date: 19Jul2021, when the patient was 12-year-old, for COVID-19 immunization, reaction: "Inappropriate schedule of vaccine administered"; BNT162b2 (Dose Number: 1, Batch/Lot No: EW0186), administration date: 29May2021, when the patient was 12-year-old, for COVID-19 Immunization. The following information was reported: ALOPECIA AREATA (non-serious) with onset May2022, outcome "recovering". The event "alopecia areata" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of alopecia areata.  Additional Information: The facility type that the vaccine was administered was a pharmacy or drug store. The patient had not received any other vaccines in four weeks. About 1 month after the reporter's daughter's 3rd COVID vaccine, the reporter noticed about 4 bald spots on the back of the patient's head. It was completely smooth with bald spots. The pediatrician referred them to a dermatologist, who diagnosed the patient with alopecia areata. She received multiple triamcinolone injections in the areas of hair loss at that visit. The patient did not have a COVID prior vaccination and had a COVID test post vaccination.
I received 2nd booster shot on 11/20/2021. Adverse event on 12/15/2021 in the morning 10:00, I noticed that both of my knees and hips were stiff. I was at work then I came home and tried to take rest. I tried excising. I started to move my knees and hips. I wasn't sure if I wasn't moving correctly. Then I called my doctor and saw the doctor. He took x-rays of my both knees and hips. My doctor recommend me to a physical therapist. I went there for 3 months. He diagnosed as tendinitis. After my therapist, I was assigned to do stretches' at home 10 minutes per day. Then I went for my second booster same thing happened. There was stiffness on my knees and hips but more on my hips then my knees. I took Aspirin, Tylenol and ibuprofen for my pain. The only medication that helped was ibuprofen. I also took turmeric 15mg. I took one per day it really helped.
Patient lost consciousness for a second and collapsed on the floor. He was conscious and aware of his surrounding just a few seconds after the incident
This spontaneous report was received from a pharmacist refers to a male patient of unknown age. No pertinent medical history of the patient was reported. On 21-NOV-2014 the patient was vaccinated with ZOSTAVAX lot # K009773, expiry date: 09-OCT-2015, 0.65 ml, subcutaneous (site of administration was unspecified). There were no concomitant medications reported. On an unknown date in January 2015, reported as within the last week, the patient experienced an upper respiratory infection. The patient sought medical attention by visiting the emergency room (ER) at the hospital and was prescribed with prednisone (manufacturer unknown) and the patient was also treated with azithromycin. There was no product quality complaint involved. The outcome of upper respiratory infection was unknown. The causality of the event was not reported. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. In 2007/2008, the patient was vaccinated with the first dose of GARDASIL. The pharmacist stated that an unspecified patient wished to receive 2nd and 3rd dose of GARDASIL although she was unsure of her vaccine history. Additional information has been requested.